Drugs / Ispaghula husk
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00748787 | Oct 2008 → Nov 2009 | metabolic syndrome X | Rottapharm Spain | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00589771 Background | Jan 2010 → Dec 2011 | irritable bowel syndrome | Aga Khan University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ispaghula husk | “Ispaghula husk 1 Tsf daily after dinner for six weeks” NCT00589771 ↗ |
| Route | Oral | “Oral route.” NCT00748787 ↗ |